Stacey DaCosta Byfield

SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7

Stacey DaCosta Byfield, Christopher Major, Nicholas J. Laping et al. · Molecular Pharmacology · 2004 · 412 citations

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

Douglas E. Levy, Stacey DaCosta Byfield, Catherine Comstock et al. · Genetics in Medicine · 2011 · 239 citations · Full text

Hispanic Women, Breast Oncology, Cancer Risk +10

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β

Christina H. Stuelten, Stacey DaCosta Byfield, Praveen Arany et al. · Journal of Cell Science · 2005 · 236 citations · Full text

Loss of Smad3 in Acute T-Cell Lymphoblastic Leukemia

Lawrence A. Wolfraim, Tania Miñes Fernández, Mizuko Mamura et al. · New England Journal of Medicine · 2004 · 164 citations · Full text

Smad-Binding Defective Mutant of Transforming Growth Factor β Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines

Fang Tian, Stacey DaCosta Byfield, W. Tony Parks et al. · Cancer Research · 2004 · 83 citations